A carregar...
Enrichment Benefits of Risk Algorithms for Pulmonary Arterial Hypertension Clinical Trials
Rationale: Event-driven primary endpoints are increasingly used in pulmonary arterial hypertension clinical trials, substantially increasing required sample sizes and trial lengths. The U.S. Food and Drug Administration advocates the use of prognostic enrichment of clinical trials by preselecting a...
Na minha lista:
| Publicado no: | Am J Respir Crit Care Med |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Thoracic Society
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7958501/ https://ncbi.nlm.nih.gov/pubmed/32937078 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1164/rccm.202002-0357OC |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|